Publications (16) Publications de MARÍA JOSÉ DEVESA MEDINA

2020

  1. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

    Hepatology, Vol. 72, Núm. 6, pp. 1924-1934

2019

  1. HIV coinfection predicts failure of ledipasvir/sofosbuvir in treatment-naïve noncirrhotic patients with HCV genotype

    Open Forum Infectious Diseases, Vol. 6, Núm. 5

2017

  1. Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

    Journal of Viral Hepatitis, Vol. 24, Núm. 4, pp. 304-311

  2. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience

    Journal of Viral Hepatitis, Vol. 24, Núm. 6, pp. 464-471

2015

  1. Actualización terapéutica en la hepatitis C

    Revista Espanola de Quimioterapia, Vol. 28, pp. 48-51

  2. Perfil clínico y seguimiento de los pacientes con hepatitis C crónica en hospitales españoles: Estudio disHCovery

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 145-153

2014

  1. Las máquinas de diagnosticar y sus inventores

    You and Us

2013

  1. Advantages of early cholecystectomy in clinical practice of a terciary care center

    Hepatobiliary and Pancreatic Diseases International, Vol. 12, Núm. 1, pp. 87-93

  2. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

    Annals of Hepatology, Vol. 12, Núm. 2, pp. 199-204

2012

  1. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  2. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

2010

  1. Epónimos en aparato digestivo

    You and Us

  2. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

    Scandinavian Journal of Gastroenterology, Vol. 45, Núm. 1, pp. 51-59

2008

  1. "12 Weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: Two prognostic categories under the same label?

    Scandinavian Journal of Gastroenterology, Vol. 43, Núm. 8, pp. 979-983

2007

  1. Utilidad de la biopsia hepática en el diagnóstico etiológico de las alteraciones de la analítica hepática de causa incierta

    Gastroenterologia y Hepatologia, Vol. 30, Núm. 6, pp. 325-330

2004

  1. Protocolo diagnóstico de la disfagia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 1, pp. 37-40